Dose Finding Phase 1 Study of the Treatment of Recurrent/Relapsed Glioblastoma Multiforme With MPC-6827 in Combination With Carboplatin.

Trial Profile

Dose Finding Phase 1 Study of the Treatment of Recurrent/Relapsed Glioblastoma Multiforme With MPC-6827 in Combination With Carboplatin.

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Mar 2011

At a glance

  • Drugs Carboplatin; Verubulin
  • Indications Glioblastoma
  • Focus Adverse reactions
  • Sponsors Myrexis
  • Most Recent Events

    • 24 Mar 2011 Planned end date changed from 1 Aug 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
    • 28 May 2010 Updated information on this trial will be presented as a poster at ASCO 2010, according to a Myriad Pharmaceuticals media release.
    • 20 May 2010 19 patients have been accrued to this study as at 7 December 2009, according to a Myriad Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top